🇺🇸 Cisplatine in United States

746 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 163 reports (21.85%)
  2. Off Label Use — 97 reports (13%)
  3. Diarrhoea — 78 reports (10.46%)
  4. Pancytopenia — 69 reports (9.25%)
  5. Neutropenia — 66 reports (8.85%)
  6. Thrombocytopenia — 62 reports (8.31%)
  7. Vomiting — 60 reports (8.04%)
  8. Anaemia — 57 reports (7.64%)
  9. Nausea — 48 reports (6.43%)
  10. Dyspnoea — 46 reports (6.17%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Cisplatine approved in United States?

Cisplatine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Cisplatine in United States?

Lymphoma Study Association is the originator. The local marketing authorisation holder may differ — check the official source linked above.